News Roundup: January 30 to February 3
Your weekly roundup of the latest news from Drug Topics®.
Bills Safety Damar Hamlin Launches #3forHeart CPR Challenge
After an on-field cardiac arrest, Hamlin partnered with the American Heart Association to spotlight the importance of CPR
COVID-19 Vaccine Prices Set to Surge
Pfizer Inc. and Moderna Inc. have indicated that they are going to price their shots at between $110 and $130. The shots should still be free to individuals because of rules barring out-of-pocket costs for such vaccinations.
Odactra Approved by FDA for Treatment of House Dust Mite-Induced Allergic Rhinitis
Odactra, a tablet for treating pediatric house dust mite-induced allergic rhinitis, has been approved by the US Food and Drug Administration for patients aged 12 to 17 years.
2023 Technology Trends: Examining the Impact on Independent Pharmacy
A new report unpacks some of the challenges that independent pharmacists may face in the years ahead.
COVID-19 National Emergencies to End in May
The public health emergency, which was set to end April 11, and the national emergency, which was set to end March 1, will be ended on May 11 by the Biden administration.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
